Cartesian Therapeutics (RNAC)
NASDAQ:RNAC
Holding RNAC?
Track your performance easily

Cartesian Therapeutics (RNAC) Ownership - Who Owns Cartesian Therapeutics?

1,072 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 14, 2024
Timothy A Springer
Director, >10% Owner
xxxxxxxxxxxxx
$101964
Aug 14, 2024
xxxxxxxxxxxxx
$95250
Mar 28, 2024
Timothy A Springer
Director, >10% Owner
xxxxxxxxxxxxx
$11388
Mar 20, 2024
Timothy A Springer
Director, >10% Owner
xxxxxxxxxxxxx
$11236

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
528,838Institution2.47%8,794,576
509,159Institution2.38%8,467,314
490,320Institution2.29%8,154,022
325,308Institution1.52%5,409,872
261,427Institution1.22%4,347,531
219,092Institution1.02%3,643,500
183,168Institution0.86%3,046,084
118,442Institution0.55%1,969,690
109,236Institution0.51%1,816,595
94,737Institution0.44%1,575,476

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
528,838Institution2.47%8,794,576
509,159Institution2.38%8,467,314
490,320Institution2.29%8,154,022
325,308Institution1.52%5,409,872
183,168Institution0.86%3,046,084
118,442Institution0.55%1,969,690
109,236Institution0.51%1,816,595
94,737Institution0.44%1,575,476
85,524Institution0.40%1,422,264
59,395Institution0.28%987,739

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
182,751Institution0.85%3,039,149
126,634Institution0.59%2,064,134
62,072Institution0.29%1,032,257
56,534Institution0.26%921,504
28,371Institution0.13%462,447
16,604Institution0.08%276,125
6,937Institution0.03%113,073
4,079Institution0.02%65,305
1,440Institution<0.01%23,054
616Institution<0.01%10,041

FAQ

Who Owns Cartesian Therapeutics (RNAC)?
Currently, no data Available
What percentage of Cartesian Therapeutics (RNAC) stock is held by institutional investors?
Currently, no data Available
What percentage of Cartesian Therapeutics (RNAC) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Cartesian Therapeutics (RNAC)?
VANGUARD EXPLORER FUND owns the most shares of Cartesian Therapeutics (RNAC).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis